Journal of Pulmonology and Clinical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Case Report - Journal of Pulmonology and Clinical Research (2023) Volume 6, Issue 5

Treatment that preserves fertility for cervical adenocarcinomas that are in situ and early-stage invasive.

Katie Newhart *

Department of Medical Genetics, University of Helsinki, Helsinki, Finland

*Corresponding Author:
Katie Newhart
Department of Medical Genetics
University of Helsinki
Helsinki, Finland

Received:28-Aug-2023, Manuscript No. AAJPCR-23-112543; Editor assigned:31-Aug-2023, PreQC No. AAJPCR-23-112543 (PQ); Reviewed:14-Sep-2023, QC No. AAJPCR-23-112543; Revised:20-Sep-2023, Manuscript No. AAJPCR-23-112543 (R); Published:27-Sep-2023, DOI:10.35841/ /aajpcr-6.5.166

Citation: Newhart K. Treatment that preserves fertility for cervical adenocarcinomas that is in situ and early-stage invasive. J Pulmonol Clin Res. 2023;6(5):166

Visit for more related articles at Journal of Pulmonology and Clinical Research


Despite the fact that the word "adenocarcinoma" may not be recognizable to you, it refers to one of the most prevalent and serious kinds of cancer that can be detected in many organs all throughout the human body. Since glandular tissues are in charge of creating and secreting fluids like mucus, hormones, and enzymes, this type of cancer is distinguished by the fact that it develops there. In addition to the colon and pancreas, adenocarcinomas can develop in the lungs, prostate, breast, pancreas, and other organs. Adenocarcinoma presents particular potential and problems in the field of oncology due to its wide range of sites and the vital activities of these glands [1].

For both patients and physicians, cervical adenocarcinoma, a form of cervical cancer, poses a special challenge. This cancer kind, which is most usually diagnosed in young and premenopausal women, not only puts their lives in danger but also causes them to worry about preserving their fertility. The female reproductive system's most important component, the cervix, is fundamental to having children. As a result, managing cervical adenocarcinomas now involves addressing the dual goals of cancer treatment and fertility preservation [2].

The cervical adenocarcinomas at cervical adenocarcinomas before we discuss fertility-preserving therapies. These tumors develop in the glandular cells that line the cervix, the lowest portion of the uterus that joins to the vagina. Adenocarcinomas of the cervix, though less frequent than the more typical squamous cell carcinoma, are more common in younger female patients. For successful therapy, early detection is crucial [3].

Radical operations, including a hysterectomy, which removes the uterus and, with it, all hope of subsequent pregnancies, are frequently used as part of standard therapies for cervical cancer. Even while these treatments are successful in curing cancer, they may have a significant negative effect on a woman's ability to conceive, especially if she wants children [4].

The cervix is cleaned of a cone-shaped portion of tissue that contains malignant cells. This treatment can protect fertility while potentially curing early-stage adenocarcinoma. A trachelectomy, which removes the cervix while leaving the uterus intact, may be used in certain circumstances. Through the use of assisted reproductive technology, this operation opens the door to potential future pregnancies. Chemotherapy before surgery can aid in tumor reduction, potentially enabling less invasive surgical techniques while maintaining fertility. Radiation therapy or a radiation and chemotherapy combination may be utilized if surgery is not an option. These therapies try to eliminate cancer while, if at all feasible, preserving the uterus [5].


The prospect of becoming pregnant can still exist after receiving a diagnosis of cervical cancer. Many young women who are dealing with this difficult diagnosis are finding that retaining fertility is becoming a more viable option thanks to advancements in medical research and specific treatment options. However, it is crucial to address each case separately, taking into account the patient's particular circumstances and the cancer's stage.


  1. Al-Kalbani M, McVeigh G, Nagar H, et al. Do FIGO Stage IA and Small (? 2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery? Int J Gynecol Cancer. 2012;22(2).
  2. Indexed at, Google Scholar, Cross Ref

  3. Tewari KS, Di Saia PJ. Ovulatory failure, fertility preservation and reproductive strategies in the setting of gynecologic and non-gynecologic malignancies. Eur J Gynaecol Oncol. 2006;27(5):449-61.
  4. Indexed at, Google Scholar

  5. Plante M. Evolution in fertility-preserving options for early-stage cervical cancer: Radical trachelectomy, simple trachelectomy, neoadjuvant chemotherapy. Int J Gynecol Cancer. 2013;23(6).
  6. Indexed at, Google Scholar, Cross Ref

  7. Monti E, Somigliana E, Alberico D, et al. Conservative treatment for cervical adenocarcinoma in situ: Long-term results. J Low Genit Tract Dis. 2022;26(4):293-7.
  8. Indexed at, Google Scholar, Cross Ref

  9. Makar AP, Tropé C. Fertility preservation in gynecologic cancer. Acta Obstet Gynecol Scand. 2001;80(9):794-802.
  10. Indexed at, Google Scholar, Cross Ref

Get the App